SCHEMBL15568711

SCHEMBL15568711

O=Cc1cc(F)c(O)c(OCCCF)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.42
STAT3 P40763 2/20 0.42
NFE2L2 Q16236 2/20 0.42
PTGES O14684 1/20 0.42
PTGS1 P23219 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
APP P05067 2/20 0.41
FDPS P14324 1/20 0.38
ALDH1A1 P00352 3/20 0.37
ERN1 O75460 2/20 0.36
CYP2C9 P11712 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8996063 0.86 KDM4E (0.47) ALOX5STAT3NFE2L2PTGESPTGS1
SCHEMBL15566912 0.84 ALDH1A1 (0.41) ALOX5KDM4EAPPFDPSALDH1A1
SCHEMBL9065484 0.84 KDM4E (0.48) ALOX5STAT3NFE2L2PTGESPTGS1
SCHEMBL1515768 0.80 KDM4E (0.61) ALOX5STAT3NFE2L2PTGESPTGS1
SCHEMBL15567759 0.76 FDPS (0.51) ALOX5STAT3NFE2L2PTGESPTGS1
SCHEMBL564282 0.76 ALOX5 (0.66) ALOX5STAT3NFE2L2PTGESPTGS1
SCHEMBL15952417 0.74 ALDH1A1 (0.56) KDM4EAPPFDPSALDH1A1CYP2C9
SCHEMBL1922945 0.74 ERN1 (0.52) ALOX5STAT3NFE2L2KDM4ENFKB1
SCHEMBL13907556 0.74 ERN1 (0.51) KDM4EAPPERN1MAPTSMN1; SMN2
SCHEMBL8996034 0.72 ALOX5 (0.49) ALOX5STAT3NFE2L2PTGESPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885306-B1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2016-06-01 EP disclosed
EP-2885306-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. Hoffmann-La Roche AG (CH) 2015-06-24 EP disclosed
US-20150157739-A1 Imidazo[2,1]thiazol-3-one derivatives HOFFMANN-LA ROCHE INC. (US) 2015-06-11 US disclosed
WO-2014026881-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2014-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150157739-A1 Imidazo[2,1]thiazol-3-one derivatives MAPT, SNCA, PARK7 ALOX5 4761/4885STAT3 1423/4885NFE2L2 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.